Literature DB >> 6354290

Sample-size formula for the proportional-hazards regression model.

D A Schoenfeld.   

Abstract

A formula is derived for determining the number of observations necessary to test the equality of two survival distributions when concomitant information is incorporated. This formula should be useful in designing clinical trials with a heterogeneous patient population. Schoenfeld (1981, Biometrika 68, 316-319) derived the asymptotic power of a class of statistics used to test the equality of two survival distributions. That result is extended to the case where concomitant information is available for each individual and where the proportional-hazards model holds. The loss of efficiency caused by ignoring concomitant variables is also computed.

Entities:  

Mesh:

Year:  1983        PMID: 6354290

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  238 in total

1.  Duration of accrual and follow-up for two-stage clinical trials.

Authors:  L D Case; T M Morgan
Journal:  Lifetime Data Anal       Date:  2001-03       Impact factor: 1.588

2.  Sample size calculation for rank tests comparing K survival distributions.

Authors:  Sin-Ho Jung; Siu Hui
Journal:  Lifetime Data Anal       Date:  2002-12       Impact factor: 1.588

3.  A replication study and genome-wide scan of single-nucleotide polymorphisms associated with pancreatic cancer risk and overall survival.

Authors:  Jason A Willis; Sara H Olson; Irene Orlow; Semanti Mukherjee; Robert R McWilliams; Robert C Kurtz; Robert J Klein
Journal:  Clin Cancer Res       Date:  2012-06-04       Impact factor: 12.531

4.  Associations in the course of personality disorders and Axis I disorders over time.

Authors:  M Tracie Shea; Robert L Stout; Shirley Yen; Maria E Pagano; Andrew E Skodol; Leslie C Morey; John G Gunderson; Thomas H McGlashan; Carlos M Grilo; Charles A Sanislow; Donna S Bender; Mary C Zanarini
Journal:  J Abnorm Psychol       Date:  2004-11

5.  Mapping temporally varying quantitative trait loci in time-to-failure experiments.

Authors:  Frank Johannes
Journal:  Genetics       Date:  2006-12-06       Impact factor: 4.562

6.  The sample size required for intervention studies on fracture prevention can be decreased by using a bone resorption marker in the inclusion criteria: prospective study of a subset of the Nagano Cohort, on behalf of the Adequate Treatment of Osteoporosis (A-TOP) Research Group.

Authors:  Masataka Shiraki; Tatsuhiko Kuroda; Toshitaka Nakamura; Masao Fukunaga; Takayuki Hosoi; Hajime Orimo; Kuniyoshi Makino
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

7.  The addition of paclitaxel to doxorubicin and cisplatin and volume-directed radiation does not improve overall survival (OS) or long-term recurrence-free survival (RFS) in advanced endometrial cancer (EC): A randomized phase III NRG/Gynecologic Oncology Group (GOG) study.

Authors:  Nick M Spirtos; Danielle Enserro; Howard D Homesley; Susan K Gibbons; David Cella; Robert T Morris; Koen DeGeest; Roger B Lee; David S Miller
Journal:  Gynecol Oncol       Date:  2019-04-30       Impact factor: 5.482

8.  Obstructive sleep apnea as a risk factor for coronary events or cardiovascular death.

Authors:  Neomi A Shah; Henry Klar Yaggi; John Concato; Vahid Mohsenin
Journal:  Sleep Breath       Date:  2009-09-24       Impact factor: 2.816

9.  Obstructive sleep apnea as a risk factor for type 2 diabetes.

Authors:  Nader Botros; John Concato; Vahid Mohsenin; Bernardo Selim; Kervin Doctor; Henry Klar Yaggi
Journal:  Am J Med       Date:  2009-12       Impact factor: 4.965

10.  Personality facets and all-cause mortality among Medicare patients aged 66 to 102 years: a follow-on study of Weiss and Costa (2005).

Authors:  Paul T Costa; Alexander Weiss; Paul R Duberstein; Bruce Friedman; Ilene C Siegler
Journal:  Psychosom Med       Date:  2014-06       Impact factor: 4.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.